R1 RCM (RCM) to Release Earnings on Wednesday

R1 RCM (NASDAQ:RCM) is scheduled to post its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect R1 RCM to post earnings of ($0.05) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

R1 RCM Stock Performance

R1 RCM stock opened at $12.47 on Monday. R1 RCM has a 52-week low of $8.87 and a 52-week high of $18.70. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.57. The firm’s fifty day moving average is $12.98 and its 200 day moving average is $11.43.

Insider Activity at R1 RCM

In other news, President John M. Sparby sold 10,046 shares of the firm’s stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $14.33, for a total transaction of $143,959.18. Following the transaction, the president now directly owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 36.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Citigroup raised R1 RCM from a “neutral” rating to a “buy” rating and set a $16.00 price objective on the stock in a research note on Wednesday, March 20th. Guggenheim cut their target price on R1 RCM from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, April 5th. Barclays restated an “equal weight” rating and set a $14.00 price target on shares of R1 RCM in a report on Wednesday, February 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $19.00 price objective on shares of R1 RCM in a research note on Thursday, March 7th. Finally, Canaccord Genuity Group reduced their target price on shares of R1 RCM from $17.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, March 20th. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $16.87.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.